MRD (Minimal Residual Disease) refers to the state of a small amount of tumor cells remaining in the body after treatment of malignant tumors, which is the root cause of tumor recurrence. Accurate MRD detection is the basis for personalized precision medicine for patients.
The global market for MRD Detection was estimated to be worth US$ 2314 million in 2023 and is forecast to a readjusted size of US$ 3481 million by 2030 with a CAGR of 6.0% during the forecast period 2024-2030
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for MRD Detection, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of MRD Detection by region & country, by Type, and by Application.
The MRD Detection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding MRD Detection.
Market Segmentation
By Company
Neoimmune
Labcorp Inc
F.Hoffmann-La Roche Ltd.
GuardantHealth
Sysmex Corporation
NeoGenomics Laboratories, Inc.
AdaptiveBiotechnologies Corporation
ArcherDX, Inc.
Asuragen Inc.
Arup Laboratories Inc.
Bio-Rad Laboratories
Opko Health
Quest Diagnostics
ICON plc
Cergentis B.V.
Segment by Type:
Flow Cytometer
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Segment by Application
Scientific Research Unit
Medical School
CDC
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of MRD Detection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of MRD Detection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of MRD Detection in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 MRD Detection Product Introduction
1.2 Global MRD Detection Market Size Forecast
1.2.1 Global MRD Detection Sales Value (2019-2030)
1.2.2 Global MRD Detection Sales Volume (2019-2030)
1.2.3 Global MRD Detection Sales Price (2019-2030)
1.3 MRD Detection Market Trends & Drivers
1.3.1 MRD Detection Industry Trends
1.3.2 MRD Detection Market Drivers & Opportunity
1.3.3 MRD Detection Market Challenges
1.3.4 MRD Detection Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global MRD Detection Players Revenue Ranking (2023)
2.2 Global MRD Detection Revenue by Company (2019-2024)
2.3 Global MRD Detection Players Sales Volume Ranking (2023)
2.4 Global MRD Detection Sales Volume by Company Players (2019-2024)
2.5 Global MRD Detection Average Price by Company (2019-2024)
2.6 Key Manufacturers MRD Detection Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers MRD Detection Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of MRD Detection
2.9 MRD Detection Market Competitive Analysis
2.9.1 MRD Detection Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by MRD Detection Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in MRD Detection as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Flow Cytometer
3.1.2 Polymerase Chain Reaction (PCR)
3.1.3 Next Generation Sequencing (NGS)
3.2 Global MRD Detection Sales Value by Type
3.2.1 Global MRD Detection Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global MRD Detection Sales Value, by Type (2019-2030)
3.2.3 Global MRD Detection Sales Value, by Type (%) (2019-2030)
3.3 Global MRD Detection Sales Volume by Type
3.3.1 Global MRD Detection Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global MRD Detection Sales Volume, by Type (2019-2030)
3.3.3 Global MRD Detection Sales Volume, by Type (%) (2019-2030)
3.4 Global MRD Detection Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Scientific Research Unit
4.1.2 Medical School
4.1.3 CDC
4.1.4 Other
4.2 Global MRD Detection Sales Value by Application
4.2.1 Global MRD Detection Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global MRD Detection Sales Value, by Application (2019-2030)
4.2.3 Global MRD Detection Sales Value, by Application (%) (2019-2030)
4.3 Global MRD Detection Sales Volume by Application
4.3.1 Global MRD Detection Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global MRD Detection Sales Volume, by Application (2019-2030)
4.3.3 Global MRD Detection Sales Volume, by Application (%) (2019-2030)
4.4 Global MRD Detection Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global MRD Detection Sales Value by Region
5.1.1 Global MRD Detection Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global MRD Detection Sales Value by Region (2019-2024)
5.1.3 Global MRD Detection Sales Value by Region (2025-2030)
5.1.4 Global MRD Detection Sales Value by Region (%), (2019-2030)
5.2 Global MRD Detection Sales Volume by Region
5.2.1 Global MRD Detection Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global MRD Detection Sales Volume by Region (2019-2024)
5.2.3 Global MRD Detection Sales Volume by Region (2025-2030)
5.2.4 Global MRD Detection Sales Volume by Region (%), (2019-2030)
5.3 Global MRD Detection Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America MRD Detection Sales Value, 2019-2030
5.4.2 North America MRD Detection Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe MRD Detection Sales Value, 2019-2030
5.5.2 Europe MRD Detection Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific MRD Detection Sales Value, 2019-2030
5.6.2 Asia Pacific MRD Detection Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America MRD Detection Sales Value, 2019-2030
5.7.2 South America MRD Detection Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa MRD Detection Sales Value, 2019-2030
5.8.2 Middle East & Africa MRD Detection Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions MRD Detection Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions MRD Detection Sales Value
6.2.1 Key Countries/Regions MRD Detection Sales Value, 2019-2030
6.2.2 Key Countries/Regions MRD Detection Sales Volume, 2019-2030
6.3 United States
6.3.1 United States MRD Detection Sales Value, 2019-2030
6.3.2 United States MRD Detection Sales Value by Type (%), 2023 VS 2030
6.3.3 United States MRD Detection Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe MRD Detection Sales Value, 2019-2030
6.4.2 Europe MRD Detection Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe MRD Detection Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China MRD Detection Sales Value, 2019-2030
6.5.2 China MRD Detection Sales Value by Type (%), 2023 VS 2030
6.5.3 China MRD Detection Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan MRD Detection Sales Value, 2019-2030
6.6.2 Japan MRD Detection Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan MRD Detection Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea MRD Detection Sales Value, 2019-2030
6.7.2 South Korea MRD Detection Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea MRD Detection Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia MRD Detection Sales Value, 2019-2030
6.8.2 Southeast Asia MRD Detection Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia MRD Detection Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India MRD Detection Sales Value, 2019-2030
6.9.2 India MRD Detection Sales Value by Type (%), 2023 VS 2030
6.9.3 India MRD Detection Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Neoimmune
7.1.1 Neoimmune Company Information
7.1.2 Neoimmune Introduction and Business Overview
7.1.3 Neoimmune MRD Detection Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Neoimmune MRD Detection Product Offerings
7.1.5 Neoimmune Recent Development
7.2 Labcorp Inc
7.2.1 Labcorp Inc Company Information
7.2.2 Labcorp Inc Introduction and Business Overview
7.2.3 Labcorp Inc MRD Detection Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Labcorp Inc MRD Detection Product Offerings
7.2.5 Labcorp Inc Recent Development
7.3 F.Hoffmann-La Roche Ltd.
7.3.1 F.Hoffmann-La Roche Ltd. Company Information
7.3.2 F.Hoffmann-La Roche Ltd. Introduction and Business Overview
7.3.3 F.Hoffmann-La Roche Ltd. MRD Detection Sales, Revenue and Gross Margin (2019-2024)
7.3.4 F.Hoffmann-La Roche Ltd. MRD Detection Product Offerings
7.3.5 F.Hoffmann-La Roche Ltd. Recent Development
7.4 GuardantHealth
7.4.1 GuardantHealth Company Information
7.4.2 GuardantHealth Introduction and Business Overview
7.4.3 GuardantHealth MRD Detection Sales, Revenue and Gross Margin (2019-2024)
7.4.4 GuardantHealth MRD Detection Product Offerings
7.4.5 GuardantHealth Recent Development
7.5 Sysmex Corporation
7.5.1 Sysmex Corporation Company Information
7.5.2 Sysmex Corporation Introduction and Business Overview
7.5.3 Sysmex Corporation MRD Detection Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Sysmex Corporation MRD Detection Product Offerings
7.5.5 Sysmex Corporation Recent Development
7.6 NeoGenomics Laboratories, Inc.
7.6.1 NeoGenomics Laboratories, Inc. Company Information
7.6.2 NeoGenomics Laboratories, Inc. Introduction and Business Overview
7.6.3 NeoGenomics Laboratories, Inc. MRD Detection Sales, Revenue and Gross Margin (2019-2024)
7.6.4 NeoGenomics Laboratories, Inc. MRD Detection Product Offerings
7.6.5 NeoGenomics Laboratories, Inc. Recent Development
7.7 AdaptiveBiotechnologies Corporation
7.7.1 AdaptiveBiotechnologies Corporation Company Information
7.7.2 AdaptiveBiotechnologies Corporation Introduction and Business Overview
7.7.3 AdaptiveBiotechnologies Corporation MRD Detection Sales, Revenue and Gross Margin (2019-2024)
7.7.4 AdaptiveBiotechnologies Corporation MRD Detection Product Offerings
7.7.5 AdaptiveBiotechnologies Corporation Recent Development
7.8 ArcherDX, Inc.
7.8.1 ArcherDX, Inc. Company Information
7.8.2 ArcherDX, Inc. Introduction and Business Overview
7.8.3 ArcherDX, Inc. MRD Detection Sales, Revenue and Gross Margin (2019-2024)
7.8.4 ArcherDX, Inc. MRD Detection Product Offerings
7.8.5 ArcherDX, Inc. Recent Development
7.9 Asuragen Inc.
7.9.1 Asuragen Inc. Company Information
7.9.2 Asuragen Inc. Introduction and Business Overview
7.9.3 Asuragen Inc. MRD Detection Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Asuragen Inc. MRD Detection Product Offerings
7.9.5 Asuragen Inc. Recent Development
7.10 Arup Laboratories Inc.
7.10.1 Arup Laboratories Inc. Company Information
7.10.2 Arup Laboratories Inc. Introduction and Business Overview
7.10.3 Arup Laboratories Inc. MRD Detection Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Arup Laboratories Inc. MRD Detection Product Offerings
7.10.5 Arup Laboratories Inc. Recent Development
7.11 Bio-Rad Laboratories
7.11.1 Bio-Rad Laboratories Company Information
7.11.2 Bio-Rad Laboratories Introduction and Business Overview
7.11.3 Bio-Rad Laboratories MRD Detection Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Bio-Rad Laboratories MRD Detection Product Offerings
7.11.5 Bio-Rad Laboratories Recent Development
7.12 Opko Health
7.12.1 Opko Health Company Information
7.12.2 Opko Health Introduction and Business Overview
7.12.3 Opko Health MRD Detection Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Opko Health MRD Detection Product Offerings
7.12.5 Opko Health Recent Development
7.13 Quest Diagnostics
7.13.1 Quest Diagnostics Company Information
7.13.2 Quest Diagnostics Introduction and Business Overview
7.13.3 Quest Diagnostics MRD Detection Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Quest Diagnostics MRD Detection Product Offerings
7.13.5 Quest Diagnostics Recent Development
7.14 ICON plc
7.14.1 ICON plc Company Information
7.14.2 ICON plc Introduction and Business Overview
7.14.3 ICON plc MRD Detection Sales, Revenue and Gross Margin (2019-2024)
7.14.4 ICON plc MRD Detection Product Offerings
7.14.5 ICON plc Recent Development
7.15 Cergentis B.V.
7.15.1 Cergentis B.V. Company Information
7.15.2 Cergentis B.V. Introduction and Business Overview
7.15.3 Cergentis B.V. MRD Detection Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Cergentis B.V. MRD Detection Product Offerings
7.15.5 Cergentis B.V. Recent Development
8 Industry Chain Analysis
8.1 MRD Detection Industrial Chain
8.2 MRD Detection Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 MRD Detection Sales Model
8.5.2 Sales Channel
8.5.3 MRD Detection Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Neoimmune
Labcorp Inc
F.Hoffmann-La Roche Ltd.
GuardantHealth
Sysmex Corporation
NeoGenomics Laboratories, Inc.
AdaptiveBiotechnologies Corporation
ArcherDX, Inc.
Asuragen Inc.
Arup Laboratories Inc.
Bio-Rad Laboratories
Opko Health
Quest Diagnostics
ICON plc
Cergentis B.V.
听
听
*If Applicable.
